5

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: January 10, 2022
Period of Report: December 31, 2021
Accession Number: 0001127602-22-001242

View Document ↗ View on SEC.gov ↗